[Fatal Panton-Valentine leukocidine-associated Staphylococcus aureus necrotizing pneumonia]

F Laverdure1, C Neulier2, J Sudant3

  • 1Service de réanimation médico-chirurgicale, centre hospitalier de Versailles, site André-Mignot, 177, rue de Versailles, 78150 Le Chesnay, France.

Insights

Panton-Valentine leukocidin-producing Staphylococcus aureus causes severe necrotizing pneumonia with high fatality. Early diagnosis and targeted treatment, including intravenous immunoglobulin and contact management, are crucial for critical care.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Panton-Valentine leukocidin-producing Staphylococcus aureus (PVL-SA) is a rare cause of severe community-acquired pneumonia.
  • Necrotizing pneumonia associated with PVL-SA presents a high fatality rate, demanding prompt recognition.
  • Optimal management strategies, particularly for close contacts, remain incompletely understood.

Observation:

  • This case report details a patient with PVL-SA necrotizing pneumonia.
  • The report highlights the unique clinical presentation and diagnostic challenges.
  • It also addresses the specific therapeutic interventions employed.

Findings:

  • Early diagnosis and appropriate antibiotic selection are critical for patient survival.
  • Intravenous immunoglobulin (IVIg) may be considered as an adjunctive therapy.
  • Effective management protocols for close contacts are essential to prevent secondary transmission.

Implications:

  • Critical care physicians must be aware of PVL-SA necrotizing pneumonia's specific features for timely diagnosis and treatment.
  • Understanding the management of close contacts is vital for public health and infection control.
  • This case contributes to the knowledge base for managing this severe infectious disease.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
16
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
110
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K